Lawsuit Overview
August 31, 2020 - A consolidated amended complaint was filed.
March 23, 2020 - An investor in shares of RTI Surgical Holdings, Inc. (NASDAQ: RTIX) filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by RTI Surgical Holdings, Inc. in connection with certain allegedly false and misleading statements made between March 7, 2016 and March 16, 2020.
Deerfield, IL based RTI Surgical Holdings, Inc., a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. RTI Surgical Holdings, Inc. reported that its annual Total Revenue rose from $279.56 million in 2017 to $280.85 million in 2018 and that its Net Income of $6.27 million in 2017 turned into a Net Loss of $1.25 million in 2018.
On March 16, 2020, RTI Surgical Holdings, Inc. announced that it would not file its Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the Annual Report ) by the due date. The delay is due to an investigation of current and prior period matters relating to the Company's revenue recognition, primarily with OEM customers, including the accounting treatment, financial reporting, and internal controls related to such arrangements. The investigation was prompted by an ongoing SEC investigation related to the periods 2014 through 2016. Shares of RTI Surgical Holdings, Inc. (NASDAQ: RTIX) declined from $4.51 per share on February 4, 2020, to as low as $1.73 per share on March 23, 2020.
According to the complaint the plaintiff alleges on behalf of purchasers of RTI Surgical Holdings, Inc. (NASDAQ: RTIX) common shares between March 7, 2016 and March 16, 2020, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that between March 7, 2016 and March 16, 2020, the defendants made false and/or misleading statements and/or failed to disclose that the Company inappropriately recognized revenues with respect to certain contractual arrangements, including other equipment manufacturer customers, that the Company’s internal controls over financial reporting were not effective, that as a result, the Company would be forced to delay the filing of its Form 10-K for fiscal year ended December 31, 2019, and that as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.